Can a One-Year bone drug switch beat standard therapy for Steroid-Induced bone loss?
Disease control
Not yet recruiting
This study follows people with bone loss caused by long-term steroid use to compare two treatment approaches. One group received romosozumab for the first year and then switched to denosumab, while the other group took denosumab throughout. After six years, researchers will measu…
Phase: PHASE4 • Sponsor: Tuen Mun Hospital • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC